Saudi Arabia SFDA registration ME0000001000SFDAA00183

Anti-MUC1 (H23) Mouse Monoclonal Primary Antibody

Saudi Arabia flagSaudi Arabia·Chemicals·Ventana Medical Systems, Inc.·General IVD(Others)Active
Product information
Reagent directed against the membrane bound, glycosylated phosphoprotein
Product use
Anti-MUC1 (H23) Mouse Monoclonal Primary Antibody is directed against the membrane bound, glycosylated phosphoprotein MUC1. This antibody may be used to aid in the identification of normal and neoplastic MUC1 expressing cells. The antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded human tissue. MUC1 is overexpressed in breast carcinoma and non small cell lung carcinoma. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls.
Device classification
Risk Class
General IVD(Others)
Product Category
Chemicals
Product Type
IVD
Registration information
Registration ID
ME0000001000SFDAA00183
Authorization ID
GHTF-2019-0925
Status
Active
Expire Date
May 27, 2024
Manufacturer
Model information
Model ID(s)
790-4574
Product accessories
[]
About this record

Access comprehensive regulatory information for Anti-MUC1 (H23) Mouse Monoclonal Primary Antibody in the Saudi Arabia medical device market through Pure Global AI's free database. This General IVD(Others) device is registered with Saudi Arabia SFDA under registration number ME0000001000SFDAA00183 and manufactured by Ventana Medical Systems, Inc..

This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.

Free DatabasePowered by Pure Global AISFDA Official DataGeneral IVD(Others)